What's new

China’s secret weapons in trade battle with India are NTBs

@gslv mk3 deal with this riff raff would you buddy when you have time if you care to. You did an admirable job in the other thread about Indian railway manufacturing/export.

CPC trolls and their usual low-IQ posse from the neighbourhood filling up the room left by quality indian posters like parikrama. This trend looks to continue and accelerate but few remaining knowledgeable people like you should focus on a few relevant max impact threads from now on for better use of time.

I was just curious. Thank you for the reply

Don't rely on a low IQ BD troll for your information. India exports plenty of railway systems to countries that actually have a worthwhile market...something BD will never be. I will let fellow members enlighten you in this thread.
 
. .
Indian members on this thread:

@Rain Man
@Lurch Adams
@rustom
@O.P.D
@ito
@ThinkLogically
@Nilgiri
@gslv mk3

While its perfectly fine for Chinese Govt to be protectionist against Indian automobiles and service sector exports, which India leads in both, given the fact both of these are not critically necessary goods

http://www.autocarpro.in/analysis-reports/india-surpasses-china-passenger-car-exports-20224

India surpasses China in passenger car exports
by Tanmay Kulkarni Jun 07, 2016


baleno-2-699x380-699x380.jpg



volkswagen-cars-lined-up-for-shipping-from-mumbai-port-699x380.JPG



nissan1732-699x380.JPG


PreviousNext
India has beaten China in passenger car exports for the fiscal year 2015-16. According to numbers collated from SIAM statistics, Indian passenger car exports for FY2016 totaled 532,053 units. This was higher than Chinese passenger car exports for the fiscal – 409,800 units – which were recorded by the China Association Of Automobile Manufacturers. Complementing this data is the 2015 Forbes 2000 list of the world’s largest car exporting countries which lists India as the 20th largest exporter in the world compared to China, which sits at the 22nd position.

India’s position with respect to China may come as a surprise to many but this is not the first time that India has beaten China in terms of car exports. India first overtook China on the export front in 2009 with automotive exports amounting to 201,138 cars (January to July 2009) as compared to China’s 164,800.

India’s overall fortunes are also on the upswing. With the last quarter, India recorded a GDP growth of 7.9% in 2015 as opposed to China’s 6.7%, thereby maintaining its lead as the fastest growing major economy in the world.

The manufacturing sector also grew by 9.3%, an all-time high, as against 6.6% over the same period last fiscal. India’s automotive sector also emerged a winner in terms of year-on-year growth in comparison to China’s by registering an impressive annual growth rate of 8.68% as opposed to China’s 4.3%. Passenger car sales in India rose 10.18% as compared to China’s 6.5%.

Slowing down China, bouyant India

With its buoyant economy, a young population and growing foreign direct investment, India is turning out to be the silver lining for global automobile and component manufacturers. China, on the other hand, is slowing down.

Another reason for relatively lower exports from China is that its auto industry has developed extensively through foreign direct investment, which has come in the form of alliances and joint ventures between international automobile manufacturers and local partners. These international automobile manufacturers, who generally dominate the higher end of the Chinese market, have focused on making cars for China’s large domestic market. The local Chinese automakers, who occupy the lower end of the market, struggle to improve design and quality to expand sales overseas. China exports and imports relatively few vehicles as most of the cars produced in China stay in the country and its vehicle exports are mostly light trucks and passenger cars shipped to developing markets.

The majority of the Asian automotive giants do not particularly fare well in terms of car exports as can be seen from the table with the exception of Japan and South Korea which are developed economies.

top-2015-export-markets.jpg

While India contributes a mere 0.8% of the world’s car exports, China’s contribution is only 0.6% and Thailand’s 1.4%. If we compare these three countries’ cumulative contribution to the global car export scenario, they might seem to be a small piece of the pie but are becoming important due to the saturation of the European and American markets and the growing consumer demand among the population of these developing economies.

Japan and South Korea are major contributors to the global car exports with total valuations of US$ 86.1 billion and US$ 41.8 billion respectively. With exports of almost 4 million passenger cars in FY2016, Japan has been the second largest exporter in the world, behind Germany and above the US. The major export markets of Japan are the USA and European nations in the West along with Thailand and Indonesia in the ASEAN belt. South Korea also possesses an impressive export portfolio with USA and EU as one of its largest markets.

Quality and government policies to blame

In spite of all the recent improvements in infrastructure, policy making, FDI policy, the standard of living, growth in the automotive as well as auto component industry, developing economies like India, China and Thailand have not made a mark in the export of automobiles.

Even countries such as the Czech Republic and Belgium that do not possess a large automotive industry, as well as the sheer number of skilled manpower, perform much better as compared to them. Some might argue that the quality of the automobiles do not match the globally defined standards set by the EPA or Global NCAP which call for stringent checks with regards to safety and emissions while others say that the government policies with regards to taxation and production are not favorable to investors.

Also among the three Asian giants, Thailand has performed better in terms of measures undertaken to manufacture quality and affordable vehicles meeting global standards. Maruti Suzuki India planned to shift its base for the manufacturing of its Celerio model for exports to European markets to Thailand from India due to logistical and supply disadvantages. Ford Motor Co also decided to shift manufacture of its compact EcoSport SUV for North American markets from India to Thailand. Reports suggest that although India and Thailand possess similar policies related to production, they differ in terms of export logistics and supply chains wherein Thailand performs better than India. China, on the other hand, possesses a large local automobile industry but it fails to contribute at the global stage in terms of passenger car exports as a result of low-quality products. According to the statistics from CAAM, automobile exports were 54,000 units in April 2016, down 5.5% than that of the previous month, and down 12.9% year on year. Among different types, passenger car shipments comprised 34,000 units, down 8.2% on March 2016 but up 5.2% year on year, while commercial vehicle exports were 20,000 units, down 0.5% on March 2016, and down 32.5% year on year.

Lack of independent regulatory agencies

Another key reason for lower exports from the developing countries especially India and China is because a large number of organisations related to the inspection, testing, safety clearance and emission regulations are governed by different ministries and organisations and are under the control of the automotive manufacturers. This has been subject to a lot of criticism in the past as stricter compliance of automotive standards may not be followed diligently. Both Japan and South Korea have separate regulatory bodies governing policies related to testing and certification of automobiles which increases their credibility in the global scenario when it comes to export of automobiles.

India is expected to take corrective measures to drive up automobile exports. The government is making efforts to improve the criteria for setting up joint ventures and improve the transport network to enhance the logistical efficiency which will have a direct impact on exports.

http://timesofindia.indiatimes.com/...ical-exports-in-2015/articleshow/53064533.cms

India leads China in pharmaceutical exports in 2015
53064532.jpg
File photo for representation.
NEW DELHI: India maintained its supremacy over China in pharmaceutical exports in 2015 with a growth of 7.55 per cent to $12.54 billion, the commerce ministry said on Tuesday.

"India's pharmaceutical exports continued its lead over China in 2015 ... India maintains its supremacy over China in pharmaceuticals," the ministry said in a statement.

While India's pharma exports grew from $11.66 billion to $12.54 billion in 2015, recording a growth of 7.55 per cent, China's exports rose by 5.3 per cent to $6.94 billion, it added.

"India moved ahead of China in all important markets such as the US, Africa and the European Union," it added.

India's exports of pharma products to the US jumped by 23.4 per cent to $4.74 billion last year.




On the other hand, China's pharma exports to the US increased by 15 per cent to $1.34 billion in the same period.




"India also maintained its lead with growth in EU and Africa recording exports of $1.5 billion and $3.04 billion respectively, while China's exports to EU and Africa showed a declining trend in both the markets," the statement said.
India is hugely dependent on China for import of APIs, which are the raw materials for medicines. Industry and government have time and again raised concerns over increasing dependence on imported APIs from China.

India is a global hub of generic medicines. The market size of the country's pharma industry is estimated at over $20 billion.


What is really very sad is preventing Indian pharmaceutical exports critically required by Chinese citizens like Cancer drugs

Cancer patients look to India for lifesaving drugs
By Shan Juan (China Daily)Updated: 2015-01-28 07:38
CommentsPrintMailLargeMediumSmall


Leukemia patient Lu Yong borrowed the idea from the Oscar-winning film Dallas Buyers Club and smuggled unapproved, Indian-made drugs for himself and 1,000 others to get medicines at an affordable price.

Lu was detained by police in Yuanjiang, Hunan province, and his case of allegedly selling counterfeit drugs is still under investigation.

The 47-year-old textile businessman bought a month's supply of the Indian generic version of Gleevec, originally developed and manufactured by Swiss drug company Novartis, for around 200 yuan ($32).

In China, a month's supply of Gleevec costs more than 23,000 yuan, and it is not covered by health insurance in most places.

For many leukemia patients like Lu, either Gleevec or a bone-marrow transplant is the only option for survival.

Lu gave up on a transplant because donors are hard to find in China, and a transplant also carries the risk of potential major side effects. He found the cheaper Indian generic version of Gleevec worked well for him.

However, any unapproved medications are illegal in China, and the China Food and Drug Administration has issued a notice warning cancer patients not to purchase such "illegal" drugs from India through online agents.

In a joint clampdown involving public security and drug authorities, as well as major e-commerce websites like Taobao, many online agents were closed down, and some were imprisoned for selling counterfeit drugs.

Indian generic versions of other expensive cancer medications, such as Iressa, Tarceva and Nexavar, are also hot-selling items among the Chinese.

A Zhejiang-based online agent surnamed Liu said the demand is huge and ever increasing. He has been in business for four years. He quit using Taobao in late 2013 because the Chinese e-commerce giant had frozen the accounts of some Indian pharmaceutical dealers in the government-led campaign to crack down on the business.

Liu said customs checks for imports from India have also been strengthened.

"They used to just do one check in Beijing before April 2014. After that, another check was added at the destination city," Liu said.

He is now contracted with a courier service company, which receives cash from customers upon delivery.

"I contact customers, roughly 600, via cellphone and the QQ messenger service," he said. "But I never meet with them in person as it's a special business."

He said his operations in India run as normal. "It's totally legitimate there."

Jia Ping, a Beijing-based lawyer specializing in public health cases, said the Indian Patents Act, which was amended in 2005, legally bolstered the unlicensed production and marketing of the nation's generic drugs.

The amendment stipulated that only new drug compounds developed after 1995 could be protected.

Many new drugs are in fact improved versions of old drugs and thus not protected under the patent law, Jia said.

Medecins Sans Frontieres, the international NGO committed to public health, says India makes at least one-fifth of the world's generic drugs, and about half the production is sold abroad, often illegally at a fraction of the cost.

According to the National Central Cancer Registry, more than 3 million Chinese developed cancer and 1.96 million died in 2010.

Wang Jinwan, a physician at the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences, expressed deep concern over the plight of patients who cannot afford the treatments.

"I quite understand poor patients seeking to buy much cheaper drugs from India," Wang said.

Seeing 20 cancer patients each day, he said at least one-third of them give up treatment because they can't afford it.

He called on decision-makers to address the issue and help patients to stay alive longer if possible.

"To some extent, Lu Yong in China and Ron Woodroof in Dallas Buyers Club are all heroes struggling for their own and other people's lives," he said.

shanjuan@chinadaily.com.cn







0013729e4abe1632761222.jpg







0013729e4abe1632761523.jpg

Leukemia patient Lu Yong in jail in Yuanjiang, Hunan province, in January 2014, after he was detained by police for allegedly selling counterfeit drugs. Hong Kefei / for China Daily

http://www.chinadaily.com.cn/china/2015-01/28/content_19426250.htm


Chinese people willing to go as far as going to jail to fight cancer

Illegal sale of India-made cancer drugs puts Chinese couple on trial

  • Representational Image. Facebook

    Indian-made generic cancer drugs, often containing the same active ingredients as the patented medicines they are based on, sell at enormous discount compared with their patented counterparts, the report said. The vast majority of these drugs are not approved for sale in China.

    "Selling medicines produced overseas requires a certification by China's drug watchdog. If not, the drugs are seen as fake," Zhou said. In the court, Zhao said that he was trying to save people's lives, and that most of the drugs were brought for his friends instead for sale, local daily Modern Express reported.

    The case highlights India's persistent calls for China to open up its markets for Indian pharma products which have been widely approved for use in various countries to make them available for its citizens as well as to address the trade
    imbalance between the two countries
    . China says there are barriers but Indian pharmaceutical firms complain of lengthy procedures requiring years of testing for the drugs which have been approved in various markets abroad.

    Medicines in China mostly controlled by multinational markets are highly expensive making it extremely difficult for vast majority of Chinese to afford them. As a result number of Chinese traders are smuggling the Indian drugs into Chinese markets.

    India says the opening of pharma sector to it will also address the trade imbalance which is averaging over $35 billion every year. The bilateral trade volume amounts to $65.47 billion last year with balance of trade heavily tilted in favour of China. Chinese President Xi Jinping assured to address the issue during his visit to India in September this year.

    Zhou said that Zhao was sent to work in India in 2010, where he would often buy cancer medication for friends. Smelling a business opportunity, Zhao found local pharmaceutical agents willing to sell him drugs at marked-down prices and asked the agents to mail them to China.

    "They sold the medicines for over 320,000 yuan ($52,000) and made 100,000 yuan in profit," Zhou said. Local police arrested the couple in their house on 4 July after receiving a tip-off, discovering 31 boxes of generic drugs imported from India. The local procuratorate said that the medicine was not registered, and that in selling them Zhao and Ma broke the law, an offense punishable by a fine and up to three years in jail.

    Prosecutors on the case have requested sentences of a year and a half for both Zhao and Ma, with the possibility of reprieve. The court is yet to rule in the case, the Global Times report said.

    PTI

  • http://www.firstpost.com/world/ille...ugs-puts-chinese-couple-on-trial-1797567.html

 
Last edited:
.
Indian members on this thread:

@Rain Man
@Lurch Adams
@rustom
@O.P.D
@ito
@ThinkLogically
@Nilgiri
@gslv mk3

While its perfectly fine for Chinese Govt to be protectionist against Indian automobiles and service sector exports, which India leads in both, given the fact both of these are not critically necessary goods

http://www.autocarpro.in/analysis-reports/india-surpasses-china-passenger-car-exports-20224

India surpasses China in passenger car exports
by Tanmay Kulkarni Jun 07, 2016


baleno-2-699x380-699x380.jpg



volkswagen-cars-lined-up-for-shipping-from-mumbai-port-699x380.JPG



nissan1732-699x380.JPG




http://timesofindia.indiatimes.com/...ical-exports-in-2015/articleshow/53064533.cms

India leads China in pharmaceutical exports in 2015
53064532.jpg
File photo for representation.



What is really very sad is preventing Indian pharmaceutical exports critically required by Chinese citizens like Cancer drugs

Cancer patients look to India for lifesaving drugs
By Shan Juan (China Daily)Updated: 2015-01-28 07:38
CommentsPrintMailLargeMediumSmall


Leukemia patient Lu Yong borrowed the idea from the Oscar-winning film Dallas Buyers Club and smuggled unapproved, Indian-made drugs for himself and 1,000 others to get medicines at an affordable price.

Lu was detained by police in Yuanjiang, Hunan province, and his case of allegedly selling counterfeit drugs is still under investigation.

The 47-year-old textile businessman bought a month's supply of the Indian generic version of Gleevec, originally developed and manufactured by Swiss drug company Novartis, for around 200 yuan ($32).

In China, a month's supply of Gleevec costs more than 23,000 yuan, and it is not covered by health insurance in most places.

For many leukemia patients like Lu, either Gleevec or a bone-marrow transplant is the only option for survival.

Lu gave up on a transplant because donors are hard to find in China, and a transplant also carries the risk of potential major side effects. He found the cheaper Indian generic version of Gleevec worked well for him.

However, any unapproved medications are illegal in China, and the China Food and Drug Administration has issued a notice warning cancer patients not to purchase such "illegal" drugs from India through online agents.

In a joint clampdown involving public security and drug authorities, as well as major e-commerce websites like Taobao, many online agents were closed down, and some were imprisoned for selling counterfeit drugs.

Indian generic versions of other expensive cancer medications, such as Iressa, Tarceva and Nexavar, are also hot-selling items among the Chinese.

A Zhejiang-based online agent surnamed Liu said the demand is huge and ever increasing. He has been in business for four years. He quit using Taobao in late 2013 because the Chinese e-commerce giant had frozen the accounts of some Indian pharmaceutical dealers in the government-led campaign to crack down on the business.

Liu said customs checks for imports from India have also been strengthened.

"They used to just do one check in Beijing before April 2014. After that, another check was added at the destination city," Liu said.

He is now contracted with a courier service company, which receives cash from customers upon delivery.

"I contact customers, roughly 600, via cellphone and the QQ messenger service," he said. "But I never meet with them in person as it's a special business."

He said his operations in India run as normal. "It's totally legitimate there."

Jia Ping, a Beijing-based lawyer specializing in public health cases, said the Indian Patents Act, which was amended in 2005, legally bolstered the unlicensed production and marketing of the nation's generic drugs.

The amendment stipulated that only new drug compounds developed after 1995 could be protected.

Many new drugs are in fact improved versions of old drugs and thus not protected under the patent law, Jia said.

Medecins Sans Frontieres, the international NGO committed to public health, says India makes at least one-fifth of the world's generic drugs, and about half the production is sold abroad, often illegally at a fraction of the cost.

According to the National Central Cancer Registry, more than 3 million Chinese developed cancer and 1.96 million died in 2010.

Wang Jinwan, a physician at the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences, expressed deep concern over the plight of patients who cannot afford the treatments.

"I quite understand poor patients seeking to buy much cheaper drugs from India," Wang said.

Seeing 20 cancer patients each day, he said at least one-third of them give up treatment because they can't afford it.

He called on decision-makers to address the issue and help patients to stay alive longer if possible.

"To some extent, Lu Yong in China and Ron Woodroof in Dallas Buyers Club are all heroes struggling for their own and other people's lives," he said.

shanjuan@chinadaily.com.cn







0013729e4abe1632761222.jpg







0013729e4abe1632761523.jpg

Leukemia patient Lu Yong in jail in Yuanjiang, Hunan province, in January 2014, after he was detained by police for allegedly selling counterfeit drugs. Hong Kefei / for China Daily

http://www.chinadaily.com.cn/china/2015-01/28/content_19426250.htm


Chinese people willing to go as far as going to jail to fight cancer

Illegal sale of India-made cancer drugs puts Chinese couple on trial

  • Representational Image. Facebook

    Indian-made generic cancer drugs, often containing the same active ingredients as the patented medicines they are based on, sell at enormous discount compared with their patented counterparts, the report said. The vast majority of these drugs are not approved for sale in China.

    "Selling medicines produced overseas requires a certification by China's drug watchdog. If not, the drugs are seen as fake," Zhou said. In the court, Zhao said that he was trying to save people's lives, and that most of the drugs were brought for his friends instead for sale, local daily Modern Express reported.

    The case highlights India's persistent calls for China to open up its markets for Indian pharma products which have been widely approved for use in various countries to make them available for its citizens as well as to address the trade
    imbalance between the two countries
    . China says there are barriers but Indian pharmaceutical firms complain of lengthy procedures requiring years of testing for the drugs which have been approved in various markets abroad.

    Medicines in China mostly controlled by multinational markets are highly expensive making it extremely difficult for vast majority of Chinese to afford them. As a result number of Chinese traders are smuggling the Indian drugs into Chinese markets.

    India says the opening of pharma sector to it will also address the trade imbalance which is averaging over $35 billion every year. The bilateral trade volume amounts to $65.47 billion last year with balance of trade heavily tilted in favour of China. Chinese President Xi Jinping assured to address the issue during his visit to India in September this year.

    Zhou said that Zhao was sent to work in India in 2010, where he would often buy cancer medication for friends. Smelling a business opportunity, Zhao found local pharmaceutical agents willing to sell him drugs at marked-down prices and asked the agents to mail them to China.

    "They sold the medicines for over 320,000 yuan ($52,000) and made 100,000 yuan in profit," Zhou said. Local police arrested the couple in their house on 4 July after receiving a tip-off, discovering 31 boxes of generic drugs imported from India. The local procuratorate said that the medicine was not registered, and that in selling them Zhao and Ma broke the law, an offense punishable by a fine and up to three years in jail.

    Prosecutors on the case have requested sentences of a year and a half for both Zhao and Ma, with the possibility of reprieve. The court is yet to rule in the case, the Global Times report said.

    PTI

  • http://www.firstpost.com/world/ille...ugs-puts-chinese-couple-on-trial-1797567.html


self-consolation post.
 
.
I hope CRRC could set up manufacturing hubs in BD.
They have built a subsidiary in Malaysia catering for ASEAN market.


EMUs built in Malaysia
https://defence.pk/threads/made-in-malaysia-trains-manufactured-by-crrc-ipoh.459118/
View attachment 349624 View attachment 349623 View attachment 349622 View attachment 349625

Sleeper cars built for Thailand
first ever purchase of passenger cars in Thailand's history for 2 decades

Macedonia
One of the Metro in India was built in Malaysia by CRRC. Any clue which city it was?
 
.
Our exports to China and Hong Kong had been rising steadily without any issue. I don't understand by this 'permit' in the article. What is this 'permit'? The author should have explained that.
 
.
It came about because of the sound made in Northern Indian dialects (ah cha?) which means "good/ok". All these refer to Indians, not Pakistanis, like you said.

It refers to all brown people from the subcontinent.

Go ask Pakistanis here if they have the word Accha in their Urdu language, lets see if you have the guts.

Don't talk about crap you have no understanding of.

Moreover, mockery in terms of the usage of
racially based insults, typified by the derogatory term Ah Cha, appear to be
in common currency in denoting people who have originated from the
Indian subcontinent and having a darker complexion (Lai et al., 2009)


https://www.researchgate.net/public...Analysis_of_Multiple_Intersecting_Oppressions
 
.
Lol, I didn't bother to read your link.
Btw, fireworks aren't edible. How can you make something poisonous to even more poisonous? You're fucking delusional.

Read the link. It explains how Chinese crackers use banned chemicals which are highly toxic. Also, they are unstable and prone to misfire. As a person who has had the misfortune of having to buy thousands of dollars worth of crackers over the past decade for children, I should know.
 
. .
It would have been a self-consolation had Chinese companies "atleast" illegally copied Indian medicines and allowing Chinese citizens to fight cancer affordably.

But unfortunately, some Chinese drug makers prefer being slimey vermins who wish to make money by branding therir conterfiets as Indian drugs and exporting them to people in need

Made In India, Faked In China


HP-Med-0017-Stock.jpg

Illegal Chinese manufacturers are faking drugs, endangering patients’ lives, and undermining legitimate brands, especially those from India. Bian Zhenjia, deputy commissioner of the Chinese State Food and Drug Administration (SFDA), told a news conference last year that reports claiming the country was a major exporter of fake drugs were unfair. “I don’t agree with what the foreign media has been saying. The Chinese government has always paid great attention to cracking down on fake drugs.”

But new data from the drug samplings that my research team has undertaken show that China is largely responsible for the fakes attributed to India. The sample sizes are small but indicative of a larger problem, a signal that New Delhi has every right to pressure Beijing to act on rogue manufacturers within its borders.

Indian companies provide vast amounts of generic drugs to mid-income and developing nations. By some estimates, 80% of HIV drugs for the developing world come from India, and probably half the antimalarials and antibiotics too.

Counterfeiters copy popular brands even when they’re not the most expensive, since the market accepts a familiar product more easily and without suspicion. This means many fakes may be sold before they are detected. And since Indian generics dominate many therapeutic categories of these markets, it is not surprising that they are the ones faked.

India has a problem with counterfeit and substandard drugs.
My research team collected drugs from 22 cities in 20 countries over the past four years. Of these, 911 antimalarial and antibiotic products were, according to their packaging, made in India. They were procured from 14 countries, mainly in Africa, but also in Thailand and India. Of those products, 79 (or 8.7%), failed basic quality control tests and hence were unfit for their intended use. Of these 79 products, we were able to establish that 37 were counterfeits. More products may have been counterfeit, but without responses from the manufacturers or regulatory agencies, it was not always possible to be sure. Of the 37 counterfeits identified, 22 were definitely faked in China and delivered straight to African nations from China. Hence, from our small sample, over half (59%) of the fake Indian drugs were actually made in China.

Dr Paul Orhii, head of Nigeria’s anti-counterfeit drug agency NAFDAC, helped us track where some of the alleged “Indian” fakes had come from. He told us of the astonishing Chinese criminal counterfeiting drug networks his investigators had unearthed. The networks are run from China and employ Nigerians and people of other nationalities. They have successfully infiltrated the entire supply and distribution chains–from producer to patient–across continents. Orhii said they either bribed employees of customs departments, or, in numerous instances, had their own personnel apply and get jobs in places ranging from Nigerian and Chinese customs to two Middle East airlines, which then unwittingly transported the fakes from China to Nigeria.

Each compliant official had responsibility at key parts of the distribution system, starting with manufacturing in the Chinese Shenzhen free-trade zone until they arrived in Lagos, Nigeria’s largest city. Remarkably, legitimate or unbribed officials had very little chance to spot the fakes being transported. In one instance, the drug traded by a gang was a fake of an Indian antimalarial drug called Lonart DS. The proper drug is made by Bliss Gvs Pharma Ltd, of Mumbai. The fake didn’t contain any of the correct active ingredients and had it been distributed, might have left untreated thousands of malaria-stricken children. Fortunately, this shipment was caught through routine surveillance work.

But this was not the only example in 2010 where a Chinese-made fake was passed off as an Indian generic in Nigeria, said Orhii. His department has clamped down on those selling fakes from China and now it inspects factories exporting drugs to Nigeria. As a result, Beijing has sentenced six Chinese nationals to death over their part in selling fake antimalarials. The sentence is yet to be carried out.

In 2009, our Nigerian colleague Thompson Ayodele came across another fake of an Indian drug, this time an antibiotic. Later, we found out that it, too, had been made in China.

But Chinese gangs do not discriminate whose drugs to fake. Indeed, every major drug company and every country has probably had drugs faked by the Chinese. They’ll fake anything popular. Take Artesunat, the brand of a Vietnamese antimalarial, made by the Ho Chi Minh-based Mekophar Chemical Pharmaceutical. Ongoing research shows that fake Artesunat was found in Nigeria, Ghana, Kenya, Uganda and Tanzania, and also in Thailand–all the handiwork of Chinese counterfeiters.

India has a problem with counterfeit and substandard drugs. Many are made by Indians for India’s market. But it may be less India’s fault than we thought. In addition to the examples discussed above, in our ongoing research, we have even come across Chinese fakes in India that sported “Made in India” labels.

Obviously, Beijing needs to improve oversight of drug production within its borders, but India must also act. Through the World Health Organization, it must push for strengthening of public health laws against trading fake drugs. It is in India’s interest, and of patients globally, to do so.

Roger Bate is the Legatum Fellow in Global Prosperity at AEI.

Photo Credit: iStockphoto/Jason Stitt
https://www.aei.org/publication/made-in-india-faked-in-china/



Smart of your ancestors to be pre-cognitive and migrate ahead of time


You have not changed one bit in racially abusing Pakistanis have you? How disgusting, but not surprising.

Pakistanis are humans too Andrew

Actions like these prove you are no different from Imperial Japanese who were racist to Chinese during century of humiliation.

I hope you think about what I have said and change for good.

Textbook example of typical Indian style of " A Thief Crying Thief"

India, the "Undisputed fake Drugs Lord" on the planet earth, has been responsible for the death of hundreds of thousands people world wide
India is considered as the main originator and distributor of SFFC drugs.
Fake Drugs from India Present a Public Health Threat
Feb 24 2014
The World Health Organization (WHO) estimates that one in five drugs made in India are fake and that fake pharmaceuticals are a $75 billion dollar global industry. A recent New York Times article points to India as one of the countries at the forefront of the problem, selling fake drugs locally and online to unsuspecting consumers worldwide.
znezXDg.jpg

In fact, counterfeit medicines in India are harming the most vulnerable populations.
As you can see, the public-health consequences of the counterfeit drug trade are dire. Nearly 100,000 people die every year either because they’re poisoned by bad ingredients in counterfeit drugs or because the counterfeit doesn’t treat their illness. Limited access to medical care and effective treatments, the common practice of self-medication, and the availability of counterfeit drugs have also exacerbated drug resistance.
https://safemedsonline.org/2014/02/fake-drugs-india-present-public-health-threat/
 
.
Textbook example of typical Indian style of " A Thief Crying Thief"

India, the "Undisputed fake Drugs Lord" on the planet earth, has been responsible for the death of hundreds of thousands people world wide
India is considered as the main originator and distributor of SFFC drugs.
Fake Drugs from India Present a Public Health Threat
Feb 24 2014

The World Health Organization (WHO) estimates that one in five drugs made in India are fake and that fake pharmaceuticals are a $75 billion dollar global industry. A recent New York Times article points to India as one of the countries at the forefront of the problem, selling fake drugs locally and online to unsuspecting consumers worldwide.
znezXDg.jpg

In fact, counterfeit medicines in India are harming the most vulnerable populations.
As you can see, the public-health consequences of the counterfeit drug trade are dire. Nearly 100,000 people die every year either because they’re poisoned by bad ingredients in counterfeit drugs or because the counterfeit doesn’t treat their illness. Limited access to medical care and effective treatments, the common practice of self-medication, and the availability of counterfeit drugs have also exacerbated drug resistance.
https://safemedsonline.org/2014/02/fake-drugs-india-present-public-health-threat/

I knew this will hard to digest for some Chinese here, despite their contempt for mainlanders

WHO has denied these claims

WHO clarifies false media reports on India spurious

There have been some baseless, irresponsible and malicious claims in the press stating, “WHO estimates that 1 in 5 drugs made in India is a fake” and “10% to 25% of drugs in India are spurious” However, the fact is that the WHO had clarified as recently as on August 31 2012 that there was no such study carried out by the WHO.

WHO has also “regretted that occasionally some individuals in the media and the organizations use WHO references incorrectly and even irresponsibly.”

PSM India Initiative would like to make the consumers aware that WHO has made no such claims.

Kindly click on the following link that exhibits a letter from WHO India representative, Dr.Nata Menabde, who clearly states that all reports in this regard are false and totally unsubstantiated.

http://www.safemedicinesindia.in/blog_inner.php?title=WHO clarifies false media reports on India spurious

http://safemedicinesindia.in/PSMNewz/17Mar14/WHO-denial-on-spurious-drugs-study.pdf

5dkqb7.jpg
 
Last edited:
.
No injuries, I presume?

Nothing serious. But really, the problem is not just with Chinese firecrackers. I find that crackers made anywhere apart from Sivakasi in Tamil Nadu are problematic. There are now a lot of locally-made crackers everywhere in India and they are even worse than the Chinese crackers.

That said, there is a small point. I have seen that many of the firecrackers sold in Australia and US are also made in China. Now these cannot possibly be as unsafe as the ones sold here, as they would simply not pass quality and safety tests. So why are the Chinese crackers sold here so bad?

I admit that part of the problem also lies in the failure of our own safety control regime. So banning them would be the best alternative I think.
 
.
As a country, India did benefit from British legacy, from the land that British conquered to the railway Easy India Company built, but of course it came with a price. That is what I meant.

I have encountered on this forum literally hundred times when people use "chinki" "slant eyes" "small eyes" etc against Chinese members, but I never bother to report, as the use of the words against Chinese doesn't change what we are, and I believe the oversensitiveness to "discrimination" is in itself a sign of weakness.

The discussion here is more about clarifying against whom the certain terms were intended, as we do not want Pakistanis here , who provide such an open forum for people all over the world, to misunderstand Chinese. I am against use of the terms that PDF deemed to be racial slurs, but I am also against oversensitiveness, which may result an ever longer list of "forbidden words" in an otherwise open place for free speech.

I agree with you that no one benefits from current or future slurs. :enjoy:




No true. If there is a degree of "looking down" on India from Chinese members here, it is because your collective tendency to boast, from superpower 2012 to moon landing by 2020. It has nothing to do with the century of humiliation, which Chinese did not suffer in the hand of Indians. We were more or less on the same position.


Brother, NO-ONE in the world can insult the GREAT China. Within the next 15-20 years, China will become the world's 1st ever global hyper power. The most powerful nation to have ever existed. Even now, China can destroy any nation on earth. And there is nothing the enemies of China can do about it.
So the ramblings of random inferior creatures on the net cannot change this fact.
 
.
Yes, Chinese products are cheap, traders make more margin, Chinese products don't last long, so traders get more sell........and that needs to be stopped, we cannot only care about the traders' interest.
You indian if you will pay more a little on products, you will get more better products, when we quote price, you importer just like to be killed: "NO NO NO NO NO, I NEED CHEAP"

then what we should do please? dont you know the price base on quality??
 
.
hope CRRC could set up manufacturing hubs in BD.
They have built a subsidiary in Malaysia catering for ASEAN market.

I hope so, Bangladesh Railway has been undergoing a major modernization program and the modernization of the workshops are also in cards. China has so far been the largest partner in this modernization program.
 
.
Back
Top Bottom